Sphera Funds Management Ltd. Kal Vista Pharmaceuticals, Inc. Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$11.2 - $16.97 $3.54 Million - $5.37 Million	-316,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.36 - $18.28 $3.91 Million - $5.78 Million	316,200 New	316,200 $4.18 Million
Q2 2021 Aug 17, 2021	SELL	$23.12 - $29.91 $5.99 Million - $7.74 Million	-258,880 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.69 - $42.57 $275,290 - $797,761	18,740 Added 7.8%	258,880 $6.65 Million
Q1 2020 May 14, 2020	BUY	$5.8 - $18.56 $536,152 - $1.72 Million	92,440 Added 62.59%	240,140 $1.84 Million
Q4 2019 Feb 13, 2020	BUY	$10.31 - $17.81 $1.52 Million - $2.63 Million	147,700 New	147,700 $2.63 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.